Evidence map›Paper›PMID 40464002›Full record

ArticleThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale2025

Clinical Characteristics and Outcome of Readmitted Adult Patients With Acute COVID-19 Infection Within 30 Days of Their Hospital Discharge.

Nawaf Abdulaziz Alobaid, Ali Abdulrahman Alsalamah, Mohmmed Ibrahim Mugren, Abdulaziz Mohammed Alhwairini, Mohammed Ali Alzahrani, Nawaf M Alzahrani, Omar Baharoon, Jinan Shamou, Eiman Alsafi, Salim Baharoon

Abstract read
In one paragraph

Article in The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Nawaf Abdulaziz AlobaidCollege of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Ali Abdulrahman AlsalamahCollege of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Mohmmed Ibrahim MugrenCollege of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Abdulaziz Mohammed AlhwairiniCollege of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Mohammed Ali AlzahraniCollege of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Nawaf M AlzahraniKing Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Omar BaharoonCollege of Medicine, Dar Al-Uloom University, Riyadh, Saudi Arabia.
Jinan ShamouMinistry of National Guard-Health Affairs, Riyadh, Saudi Arabia.
Eiman AlsafiAl Yamamah Hospital, Riyadh Second Health Cluster, Ministry of Health, Riyadh, Saudi Arabia.
Salim BaharoonKing Abdullah International Medical Research Center, Riyadh, Saudi Arabia.ORCID https://orcid.org/0000-0001-9277-4764

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19readmissionreadmission raterisk factors

Identifiers

PMID40464002
PMCPMC12133358

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.